Bingjie Guan

1.2k citations
16 papers · 878 indexed · 1 hit paper · h-index 9
Topics
Extracellular vesicles in disease (6 papers)MicroRNA in disease regulation (5 papers)RNA modifications and cancer (2 papers)
Partner nations
ChinaThailand

In The Last Decade

Bingjie Guan

12 papers receiving 872 citations

Hit Papers

Tumor-derived exosomal miR-934 induces macrophage M2 pola...20202026202220242020100200300400500

Peers

Bingjie Guan
Comparison fields: 5 of 77
  • Molecular Biology 569
  • Cancer Research 379
  • Immunology 227
  • Oncology 142
  • Epidemiology 112
Replace Gang Cai with:
Gang Cai China
Shenmeng Gao China
Santoshi Muppala United States
Qifeng He China
Beibei Ni China
Rufu Chen China
Meng Lu China
Bingjie Guan relative to Gang Cai China Gang Cai's profile →
Citations per field
00.5×1.5×1.9×
Gang Cai · 1×
Citations per year

Countries citing papers authored by Bingjie Guan

Since Specialization
Citations

This map shows the geographic impact of Bingjie Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingjie Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingjie Guan more than expected).

Fields of papers citing papers by Bingjie Guan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingjie Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingjie Guan. The network helps show where Bingjie Guan may publish in the future.

Co-authorship network of co-authors of Bingjie Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Bingjie Guan. A scholar is included among the top collaborators of Bingjie Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingjie Guan. Bingjie Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 8
5 0
6 7
7 23
8 0
9 18
10 9
11 70
12 55
13 11
14 13
15
Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancerbreakdown →
563
16 98

About Bingjie Guan

Bingjie Guan is a scholar working on Biological Psychiatry, Cancer Research and Occupational Therapy, having authored 16 papers that have together received 878 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (6 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (379 citations), Immunology (227 citations) and Molecular Biology (569 citations). Bingjie Guan has collaborated with scholars based in China and Thailand. Frequent co-authors include Senlin Zhao, Dawei Li, Yushuai Mi, Ping Wei, Yanzi Gu, Xinxiang Li, Ye Xu, Guichao Li, Zhiyu Chen and Xinyang Zhong. Their work appears in journals such as Nature Communications, Oncogene and Archives of Biochemistry and Biophysics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026